Skip to content
healthcare.dev

FLUZONE HIGH DOSE NORTHERN HEMISPHERE

NDC 63552-722, influenza a virus a/victoria/4897/2022 ivr-238 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/croatia/10136/rv/2023 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated), injection, suspension, from Patheon Manufacturing Services LLC.

Product NDC
63552-722
Status
Listed
Labeler
Patheon Manufacturing Services LLC
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA103914
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63552-722 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)60 ug/.5mL
  • INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)60 ug/.5mL
  • INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)60 ug/.5mL
Package NDCNDC-11Package
63552-722-10635520722105 SYRINGE, GLASS in 1 PACKAGE (63552-722-10) / .5 mL in 1 SYRINGE, GLASS (63552-722-05)

Linked data

RxNorm, label and prices

Use it

Look up 63552-722 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63552-722 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63552-722. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.